["{\n\"step_by_step_thinking\": \"The question is about PRL3-zumab inhibiting PRL3+ cancer cells. The provided documents are about different topics such as carminazone, [131I]metaiodobenzylguanidine therapy, rubidazone, and cilazapril. There is no information about PRL3 or PRL3-zumab in these documents, so we cannot answer the question based on the given information.\",\n\"answer_choice\": \"B\"\n}"]